Thales reports strong growth in sales and orders, driven by defense, despite challenges in the cyber and space telecom sectors.
Roche raises profit forecast, plans major U.S. investment amid ongoing drug pricing talks.
Ryder's Q3 earnings beat expectations, but mixed segment trends amid a freight downturn leave near-term performance and the stock's sustainability dependent on management commentary and analyst estimate revisions.
Thales reports strong growth in sales and orders, driven by defense, despite challenges in the cyber and space telecom sectors.
Roche raises profit forecast, plans major U.S. investment amid ongoing drug pricing talks.
Ryder's Q3 earnings beat expectations, but mixed segment trends amid a freight downturn leave near-term performance and the stock's sustainability dependent on management commentary and analyst estimate revisions.